360 related articles for article (PubMed ID: 32099552)
1. Inhibition of microRNA-15 protects H9c2 cells against CVB3-induced myocardial injury by targeting NLRX1 to regulate the NLRP3 inflammasome.
Tong R; Jia T; Shi R; Yan F
Cell Mol Biol Lett; 2020; 25():6. PubMed ID: 32099552
[TBL] [Abstract][Full Text] [Related]
2. Involvement of NLRP3 inflammasome in CVB3-induced viral myocarditis.
Wang Y; Gao B; Xiong S
Am J Physiol Heart Circ Physiol; 2014 Nov; 307(10):H1438-47. PubMed ID: 25260607
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial calpain-1 activates NLRP3 inflammasome by cleaving ATP5A1 and inducing mitochondrial ROS in CVB3-induced myocarditis.
Liu X; Li M; Chen Z; Yu Y; Shi H; Yu Y; Wang Y; Chen R; Ge J
Basic Res Cardiol; 2022 Aug; 117(1):40. PubMed ID: 35997820
[TBL] [Abstract][Full Text] [Related]
4. NLRX1 attenuates apoptosis and inflammatory responses in myocardial ischemia by inhibiting MAVS-dependent NLRP3 inflammasome activation.
Li H; Zhang S; Li F; Qin L
Mol Immunol; 2016 Aug; 76():90-7. PubMed ID: 27393910
[TBL] [Abstract][Full Text] [Related]
5. Macrophage CAPN4 regulates CVB3-induced cardiac inflammation and injury by promoting NLRP3 inflammasome activation and phenotypic transformation to the inflammatory subtype.
Wang Y; Li M; Chen J; Yu Y; Yu Y; Shi H; Liu X; Chen Z; Chen R; Ge J
Free Radic Biol Med; 2023 Nov; 208():430-444. PubMed ID: 37660839
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-30a-5p silencing polarizes macrophages toward M2 phenotype to alleviate cardiac injury following viral myocarditis by targeting SOCS1.
Zhang Y; Cai S; Ding X; Lu C; Wu R; Wu H; Shang Y; Pang M
Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1348-H1360. PubMed ID: 33416455
[TBL] [Abstract][Full Text] [Related]
7. The Severity of CVB3-Induced Myocarditis Can Be Improved by Blocking the Orchestration of NLRP3 and Th17 in Balb/c Mice.
Chen J; Yang F; Shi S; Liu X; Qin F; Wei X; Huang Y; Liang W; Miao L
Mediators Inflamm; 2021; 2021():5551578. PubMed ID: 34093086
[TBL] [Abstract][Full Text] [Related]
8. Sema3A alleviates viral myocarditis by modulating SIRT1 to regulate cardiomyocyte mitophagy.
Lin L; Wei J; Zhu C; Hao G; Xue J; Zhu Y; Wu R
Environ Toxicol; 2023 Jun; 38(6):1305-1317. PubMed ID: 36880403
[TBL] [Abstract][Full Text] [Related]
9. MG53 protects against Coxsackievirus B3-induced acute viral myocarditis in mice by inhibiting NLRP3 inflammasome-mediated pyroptosis via the NF-κB signaling pathway.
Xue Y; Song T; Ke J; Lin S; Zhang J; Chen Y; Wang J; Fan Q; Chen F
Biochem Pharmacol; 2024 May; 223():116173. PubMed ID: 38552849
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stromal cells inhibit NLRP3 inflammasome activation in a model of Coxsackievirus B3-induced inflammatory cardiomyopathy.
Miteva K; Pappritz K; Sosnowski M; El-Shafeey M; Müller I; Dong F; Savvatis K; Ringe J; Tschöpe C; Van Linthout S
Sci Rep; 2018 Feb; 8(1):2820. PubMed ID: 29434214
[TBL] [Abstract][Full Text] [Related]
11. NOD2 (Nucleotide-Binding Oligomerization Domain 2) Is a Major Pathogenic Mediator of Coxsackievirus B3-Induced Myocarditis.
Tschöpe C; Müller I; Xia Y; Savvatis K; Pappritz K; Pinkert S; Lassner D; Heimesaat MM; Spillmann F; Miteva K; Bereswill S; Schultheiss HP; Fechner H; Pieske B; Kühl U; Van Linthout S
Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912259
[TBL] [Abstract][Full Text] [Related]
12. MiR-129-5p Protects H9c2 Cardiac Myoblasts From Hypoxia/Reoxygenation Injury by Targeting TRPM7 and Inhibiting NLRP3 Inflammasome Activation.
Liu S; Liao Q; Xu W; Zhang Z; Yin M; Cao X
J Cardiovasc Pharmacol; 2021 May; 77(5):586-593. PubMed ID: 33951695
[TBL] [Abstract][Full Text] [Related]
13. The protection effects of survivin in the cell model of CVB3-induced viral myocarditis.
Wu R; Wu T; Li P; Wang Q; Shi Y; Zhan Y; Zhang S; Xia T; Wang Z; Lv H
Heart Vessels; 2020 Aug; 35(8):1171-1179. PubMed ID: 32328712
[TBL] [Abstract][Full Text] [Related]
14. Colchicine prevents disease progression in viral myocarditis via modulating the NLRP3 inflammasome in the cardiosplenic axis.
Pappritz K; Lin J; El-Shafeey M; Fechner H; Kühl U; Alogna A; Spillmann F; Elsanhoury A; Schulz R; Tschöpe C; Van Linthout S
ESC Heart Fail; 2022 Apr; 9(2):925-941. PubMed ID: 35178861
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-495 Ameliorates Cardiac Microvascular Endothelial Cell Injury and Inflammatory Reaction by Suppressing the NLRP3 Inflammasome Signaling Pathway.
Zhou T; Xiang DK; Li SN; Yang LH; Gao LF; Feng C
Cell Physiol Biochem; 2018; 49(2):798-815. PubMed ID: 30165354
[TBL] [Abstract][Full Text] [Related]
16. Macrophage NLRP3 inflammasome activated by CVB3 capsid proteins contributes to the development of viral myocarditis.
Bao J; Sun T; Yue Y; Xiong S
Mol Immunol; 2019 Oct; 114():41-48. PubMed ID: 31336248
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of microRNA-133b reduces myocardial injuries in children with viral myocarditis by targeting Rab27B gene.
Zhang Y; Sun L; Sun H; Liu X; Luo X; Li C; Sun D; Li T
Cell Mol Biol (Noisy-le-grand); 2017 Oct; 63(10):80-86. PubMed ID: 29096746
[TBL] [Abstract][Full Text] [Related]
18. IL-37 alleviates Coxsackievirus B3-induced viral myocarditis via inhibiting NLRP3 inflammasome-mediated pyroptosis.
Sun L; Yuan H; Zhao G
Sci Rep; 2022 Nov; 12(1):20077. PubMed ID: 36418383
[TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccharide (LPS) Aggravates High Glucose- and Hypoxia/Reoxygenation-Induced Injury through Activating ROS-Dependent NLRP3 Inflammasome-Mediated Pyroptosis in H9C2 Cardiomyocytes.
Qiu Z; He Y; Ming H; Lei S; Leng Y; Xia ZY
J Diabetes Res; 2019; 2019():8151836. PubMed ID: 30911553
[TBL] [Abstract][Full Text] [Related]
20. IDO1 depletion induces an anti-inflammatory response in macrophages in mice with chronic viral myocarditis.
Guo G; Sun L; Yang L; Xu H
Cell Cycle; 2019 Oct; 18(20):2598-2613. PubMed ID: 31416389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
